Controlling Polysorbate Degradation
From the “AI Pilot Graveyard” to Enterprise- Grade Impact
Tailored Artificial Intelligence (AI)
Cloud-Native Drug Discovery
Accelerating Cross-Sector Integration in Pharma and Nutraceuticals
EDITORIAL SECTION
-
STRATEGY
Smarter Pharma
Quality management systems QMS are the backbone of pharmaceutical manufacturing ensuring safe products
-
RESEARCH DEVELOPMENT
Cytiva Laboratory capsule filters
Our singleuse selfcontained filtration solution
-
CLINICAL TRIALS
Why Clinical Trials Need Digital Endpoints
According Citeline the average success rate for bringing a Phase candidate to market has dropped to an alltime low of just
-
MANUFACTURING
Ensuring Quality and Compliance in Biopharma
Ensuring quality and regulatory compliance in the biopharmaceutical industry is critical to safeguarding product safety and efficacy
-
Information Technology
The Cost of Bad Data
Modern pharmaceutical research generates an unprecedented volume of information Data from genomic sequencing
-
Biopharma
Reimagining Global Biomanufacturing Capacity with Continuous and Modular Systems
Biotechnology is fueling the ongoing expansion of the global market for a broad array of goods
-
EXPERT Talk
Compliance to Competitive Advantage in Pharma Supply
Compliance gets you through an audit Resilience gets medicines to patients on the day something unexpected happens The DSCSAs enhanced requirements took effect November but real interoperability required three more rounds of accommodation phased implementation with the smalldispenser
Advisory Board
.webp)
KNOWLEDGE BANK
-
Articles
Oral Obesity Medicines: How Pills Could Change the European GLP-1 Market
For a decade the European obesity market has been defined by a needle a fridge and a specialist clinic In July that definition broke The European Commission granted marketing authorisation for a oncedaily mg oral semaglutide tablet making it the first GLP receptor agonist
The Synergy of Bioinformatics and Computational Biology in Genome Analysis
In the dynamic field of biological sciences the fusion of bioinformatics and computational biology has catalyzed a paradigm shift in genome analysis This synergistic collaboration harnesses cuttingedge computational tools statistical models
Advanced Robotics and Autonomous Operations in Pharma Production
Walk the production floor of almost any modern European pharmaceutical site and you will find robots already at work Sixaxis arms denest syringe tubs Gantries load and unload lyophilisers Autonomous mobile units ferry pallets between the warehouse and the dispensary Robotics arrived in pharmaceutical manufacturing more than two decades ago and in the purely mechanical sense the argument was won lo...
Emerging Therapies in Oncology: Advances beyond Traditional Chemotherapy
Cancer formerly was treated by traditional chemotherapy which is a process that employs the use of powerful drugs to eliminate spreading cancer cells Chemotherapy has been a standard for cancer treatment
Intelligent Collaborations: Navigating the Current Biopharma M&A Rebound
Biopharma MA didnt collapse in and it recalibrated Deal volumes softened valuations compressed and acquirers grew cautious as macroeconomic headwinds elevated interest rates and regulatory scrutiny made largescale consolidation feel riskier than it once had But the underlying drivers never went away They accumulated
Building Patient-Centric Clinical Trials: Technologies, Strategies, and Regulatory Considerations
Patientcentricity in clinical trials represents a crucial cultural and operational transformation in the development and evaluation of new treatments The patient experience has evolved from a secondary consideration to a central priority in trial design driven by
-
Techno Trends
Alume Biosciences Secures FDA Breakthrough Therapy Designation for Bevonescein
Alume Biosciences has received Breakthrough Therapy Designation BTD from the US Food and Drug Administration FDA for bevonescein an investigational fluorescent drug being developed to support realtime nerve visualisation during head and neck surgery in adults Bevonescein is an intravenous fluorescent peptidedye conjugate that binds to nerve tissue
-
Projects
SK pharmteco Plans More Than US$200 Million Investment in Small Molecule and Peptide Manufacturing
SK pharmteco is planning a fiveyear investment of more than US million to expand and modernise its pharmaceutical development and manufacturing operations in the United States The programme will strengthen capabilities for small molecules and peptides while supporting a more
-
Research Insights
A drug repurposing screen reveals dopamine signaling as a candidate therapeutic pathway for PIGA-CDG
PIGACDG is a congenital disorder of glycosylation caused by pathogenic partial lossoffunction variants in the PIGA gene PIGA encodes an enzyme responsible for the catalytic transfer of Nacetylglucosamine
-
whitepaper
Post-Translational Modifications in Drug Discovery: From Molecular Regulation to Clinical Impact
For decades the central dogma of molecular biology has anchored our understanding of cellular function DNA to RNA to protein But this linear view is incomplete A growing body of evidence shows that much of biologys
TOP ARTICLES
-
1
The Synergy of Bioinformatics and Computational Biology in Genome Analysis
Kate Williamson
The synergy of bioinformatics and computational biology revolutionizes genome analysis, decoding DNA sequences, gene expression patterns, protein structures, and evolutionary relationships. It empower...
-
2
Advanced Robotics and Autonomous Operations in Pharma Production
Lakshmi
European pharmaceutical plants are not short of robots. What they lack is autonomy — machines trusted to decide. This feature examines the shift from supervised automation to conditional autonom...
-
3
Emerging Therapies in Oncology: Advances beyond Traditional Chemotherapy
Sarah Richards
Chemotherapy as a method has been used together with radiation in treating cancer for many years but is associated with some drawbacks. Targeted therapy, immunotherapy, hormone therapy and precision m...
-
4
Intelligent Collaborations: Navigating the Current Biopharma M&A Rebound
Doug Drysdale
The current biopharma M&A environment reflects a market under pressure from a $300 billion patent cliff, shifting regulatory conditions, and intensifying competition across novel modalities. This...
-
5
Building Patient-Centric Clinical Trials: Technologies, Strategies, and Regulatory Considerations
Dr. Kalpana Katiyar
Ms. Shreeya Arora
Patient-centric clinical studies aim to improve the participant experience, foster diversity, enhance retention, and increase data quality. Advancements in decentralized trial models, digital health t...
press releases Read more...
Genmab and Incyte Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer
Genmab AS and Incyte announced a clinical trial collaboration to evaluate petosemtamab Genmabs investigational IgGbispecific antibody targeting the epidermal growth factor receptor EGFR and leucinerich repeat containing Gproteincoupled receptor LGR in combination with INCB Incytes investigational p...
CasZyme and Cirena to Collaborate on Developing Longer Guide RNAs to Optimise Cas12l Performance
CasZyme and Cirena have today signed an agreement that will see the two companies collaborate on further optimising the editing efficiency of CasZymes Casl CRISPR nuclease in humanrelevant applications using Cirenas synthetic nt guide RNAs
Fortrea and Omico Collaboration to Advance Biomarker-led Oncology Drug Development
Fortrea a leading global contract research organization CRO and Omico Australias leading precision oncology screening and trial matching organization today announced a collaboration to accelerate precision oncology research by helping connect cancer patients to biomarkermatched clinical trials By co...
ZEGFROVY® (sunvozertinib) now available in the US for patients with previously treated non-small cell lung cancer with EGFR exon 20 insertion mutations
AstraZeneca today announced the US availability of ZEGFROVY sunvozertinib for the treatment of adults with locally advanced or metastatic nonsmall cell lung cancer NSCLC whose tumors have epidermal growth factor receptor EGFR exon insertion mutations as detected by an FDAapproved test
Events Read more...
26 - 28
Oct 2026ACHEMA Middle East 2026
RICEC, Riyadh, KSA, Saudi Arab...
26 - 28
Oct 2026World Orphan Drug Congress
RAI, Amsterdam, Netherlands
27 - 28
Oct 2026Pharma Manufacturing & Automation Convention 2026
Novotel Hyderabad Airport, Ind...
28 - 30
Oct 2026BIOPLUS-INTERPHEX KOREA 2026
COEX, Seoul
02 - 04
Nov 2026Pharma Forum EMEA 2026
Dom Pedro Lisboa Hotel, Lisbon...
02 - 04
Nov 2026Cancer R&D 2026
Houston, TX, USA
03 - 05
Nov 202610th Dermatology Drug Development
Boston, Massachusetts at The C...
03 - 04
Nov 2026PDA Aseptic Processing of Biopharma Conference
Sheraton Grand Incheon Hotel,...
LATEST NEWS Read more...
Sacituzumab Tirumotecan (Sac-TMT) Reduced the Risk of Death by 32% and the Risk of Disease Progression or Death by 41% Compared to Chemotherapy in Patients With Recurrent Endometrial Cancer
Merck known as MSD outside of the United States and Canada today announced the first presentation of results from the pivotal Phase TroFuse trial evaluating sacituzumab tirumotecan sacTMT an investigational TROPdirected antibodydrug conjugate ADC being developed in collaboration with KelunBiotech i...
Tempus Receives IVDR Certification for xR RNA Sequencing for Solid Tumor Profiling
Tempus AI Inc announced that its xR assay has received certification under the European Unions In Vitro Diagnostic Regulation IVDR as a Class C in vitro diagnostic device The certification covers Tempus quality management system for nextgeneration sequencing devices for cancer genomic profiling to s...
Georgiamune and Menarini Group Enter Exclusive Global License and Collaboration Agreement for GIM-621, a First-in-Class Oral Immuno-Oncology Agent
The Menarini Group a leading international pharmaceutical and diagnostics company and Stemline Therapeutics Inc Stemline a whollyowned subsidiary of the Menarini Group focused on bringing transformational oncology treatments to cancer patients along with Georgiamune Inc a clinicalstage biotechnology...
LGM Pharma Acquires Sannova Analytical, Expanding cGMP Analytical and GLP Bioanalytical Services
LGM Pharma a leading provider of tailored API sourcing contract analytical testing and drug development services today announced it has acquired Sannova Analytical a contract research laboratory headquartered in Somerset NJ The acquisition expands LGM Pharmas analytical testing services business by...
AI Proteins Announces Research Collaboration and License Agreement With Astellas Pharma to Discover and Develop Novel Miniprotein-Based Therapeutics Valued at Over $400 Million
AI Proteins Inc a biotechnology company that utilizes computational de novo protein design to create therapeutic miniproteins today announced it has entered into a Research Collaboration and License Agreement with Astellas Innovation Management LLC an affiliate of Astellas Pharma Inc TSE to discove...
Okomera Announces Trade Agreement with Servier to Use Tumor Miniaturization Technology in Cancer Research
Okomera a TechBio company that personalizes cancer management with its technology combining minivatars tumor microfluidics and AI imaging today announced the signing of a commercial agreement with Servier an independent international pharmaceutical group
